Kindermann G
Geburtshilfe Frauenheilkd. 1976 Mar;36(3):213-9.
A complete answer to the question of the relationship between malignant tumors in man and the administration of contraceptive steroids is at present not possible. Difficulties of the investigation are caused by the multiplicity of compounds used for contraception, the generally slow development of malignant tumors and the difficulty of the epidemiologic and statistical investigations on the multi-factorial etiology of cancer. Nevertheless, it can be stated with a high degree of certainty that "cancer due to the pill" does not exist in man and that a direct hormonal induction of malignant tumors in man cannot be proved. The question whether oral contraceptives may favor the development of cancer indirectly is explored in this paper regarding cancer of the female genital tract and the breast. No correlation between oral contraception and squamous cell carcinomas of the vulva and vagina and tumors of the ovary is known. As yet no statistics are available on the incidence of carcinoma of the endometrium in women who took oral contraceptives during their reproductive life span. Because of the direct hormonal suppression of the endometrial growth by oral contraception, a protective effect against endometrial hyperplasia and endometrial cancer must be expected. For cancer of the female breast no protective and no enhancing cancer risk due to progestational agents can be postulated. The known fragmentary data suggest a more protective value. Regarding dysplasia and carcinoma in situ of the uterine cervix large investigations in high numbers of patients are available. An increase of the risk to develop cancer of the cervix by using oral contraception cannot be shown with sufficient accuracy at our present state of knowledge by statistical means. Some observations suggest that oral contraception increases the relevant exogenous factors for carcinogenesis of the uterine cervix such as sexual behavior and hygiene.
目前还无法完整回答人类恶性肿瘤与避孕甾体激素使用之间关系的问题。该调查存在诸多困难,原因包括用于避孕的化合物种类繁多、恶性肿瘤通常发展缓慢,以及癌症多因素病因的流行病学和统计学调查存在难度。然而,可以高度确定地说,人类不存在“避孕药导致的癌症”,且无法证明恶性肿瘤可由激素直接诱发。本文探讨了口服避孕药是否可能间接促进癌症发展的问题,涉及女性生殖道和乳腺的癌症。目前已知口服避孕药与外阴和阴道鳞状细胞癌以及卵巢肿瘤之间没有关联。对于在生育期服用口服避孕药的女性,目前尚无子宫内膜癌发病率的统计数据。由于口服避孕药对子宫内膜生长有直接的激素抑制作用,预计其对子宫内膜增生和子宫内膜癌具有保护作用。对于女性乳腺癌,无法假定孕激素会带来保护或增加患癌风险。已知的零散数据表明其具有更大的保护价值。关于子宫颈发育异常和原位癌,已有大量针对大量患者的调查。就目前的知识水平而言,通过统计方法无法充分准确地表明使用口服避孕药会增加患宫颈癌的风险。一些观察结果表明,口服避孕药会增加子宫颈致癌的相关外部因素,如性行为和卫生习惯。